Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from four suppliers. There are six patents…
The post Patent delisted for Boehringer Ingelheim drug JARDIANCE a…
Patent delisted for Boehringer Ingelheim drug JARDIANCE Read Post »
Annual Drug Patent Expirations for TARGINIQ Targiniq is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are fifteen patents protecting this drug. Drug patent…
The post Patent delisted for Purdue Pharma drug TARGINIQ appeared first…
Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers. Drug patent litigation for AMPYRA.…
The post Patent delisted for Acorda drug AMPYRA appeared first on DrugPate…
Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers. Drug patent litigation for AMPYRA.…
The post Patent delisted for Acorda drug AMPYRA appeared first on DrugPate…
Annual Drug Patent Expirations for OXYCONTIN Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from eight suppliers. There are twenty-three…
The post Patent delisted for Purdue Pharma drug OXYCONTIN appeared f…
Patent delisted for Purdue Pharma drug OXYCONTIN Read Post »
Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. There are nine patents…
The post Patent delisted for Boehringer Ingelheim drug TRADJENTA…
Patent delisted for Boehringer Ingelheim drug TRADJENTA Read Post »
Annual Drug Patent Expirations for TUDORZA+PRESSAIR Tudorza Pressair is a drug marketed by Circassia and is included in one NDA. It is available from one supplier. There are nine patents…
The post Patent delisted for Circassia drug TUDORZA PRESSAIR app…
Patent delisted for Circassia drug TUDORZA PRESSAIR Read Post »
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…
The post Patent delisted for Astrazeneca Ab drug BYDUREON PEN appear…
Patent delisted for Astrazeneca Ab drug BYDUREON PEN Read Post »
Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are twelve patents…
The post Patent delisted for Boehringer Ingelheim drug JENTADU…
Patent delisted for Boehringer Ingelheim drug JENTADUETO Read Post »
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…
The post Patent delisted for Astrazeneca Ab drug BYDUREON appeared first…
Patent delisted for Astrazeneca Ab drug BYDUREON Read Post »